Synergistic Effect of Micronutrients and Metformin in Alleviating Diabetic Nephropathy and Cardiovascular Dysfunctioning in Diabetic Rat

Overview

Journal J Diabetes Metab Disord

Specialty Endocrinology

Date 2021 Jun 28

PMID 34178853

Citations 3

Authors

Aaishwarya Deshmukh

Prajakta Manjalkar

Affiliations

Soon will be listed here.

Abstract

Purpose: Diabetic nephropathy (DN) and Cardiovascular Dysfunctioning (CVD) are interlinked with each other and one of the leading causes of irreversible renal damage and cardiovascular disease. Micronutrients play an effective role in type-2 diabetes (T2D) and its related complications. Our work aimed to elucidate the effect of micronutrients alone and in combination with standard anti-diabetic drug metformin on DN and CVD using streptozotocin induced diabetes in rats.

Methods: T2D was induced with a single intraperitoneal (i.p.) injection of freshly prepared streptozotocin (55 mg/kg), 15 min after intraperitoneal injection of nicotinamide (230 mg/kg). Commercially available kits were used to measure kidney parameters and cardiac marker level. Creatinine clearance was calculated by using formula and heart rate was recorded using powerlab software.

Results: Significant decrease in blood glucose levels were observed 14 days after initial administration in metformin treated, micronutrients treated and metformin with micronutrients treated groups compared with diabetic group. After 6 weeks of metformin and micronutrients treatment, serum creatinine, blood urea nitrogen (BUN) and lactate dehydrogenase (LDH) levels were significantly decreased as compared to diabetic group. Moreover, urine creatinine level, creatinine clearance and heart rate (HR) was increased significantly in metformin and micronutrients treated group compared with a diabetic group. Micronutrients therapy also normalised the general symptoms of diabetes.

Conclusion: The results obtained from this study indicate the synergistic effect of metformin and micronutrients against diabetic heart and kidney. Therefore, micronutrients may be used as an effective add-on therapy for DN and CVD.

Citing Articles

Evaluation of Cognitive and Synaptic Restoration in Diabetic Rats Treated With Emblica officinalis, Clitoria ternatea, Vitamin C, and Metformin.

Morampudi R, Neelakandan V, Naveen Kumar B, Indla E Cureus. 2025; 16(12):e75866.

PMID: 39822457 PMC: 11736978. DOI: 10.7759/cureus.75866.

Ameliorative effect of conjugated silver nanoparticles against chromium-induced hepatotoxicity and renal toxicity in mice.

Nauroze T, Ali S, Kanwal L, Ara C, Mughal T, Andleeb S Saudi J Biol Sci. 2023; 30(3):103571.

PMID: 36844642 PMC: 9944502. DOI: 10.1016/j.sjbs.2023.103571.

The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features.

Yan L Biomolecules. 2022; 12(9).

PMID: 36139064 PMC: 9496087. DOI: 10.3390/biom12091225.

Effects of Metformin on Renal Function, Cardiac Function, and Inflammatory Response in Diabetic Nephropathy and Its Protective Mechanism.

Zhang Z, Dong H, Chen J, Yin M, Liu F Dis Markers. 2022; 2022:8326767.

PMID: 35692885 PMC: 9187446. DOI: 10.1155/2022/8326767.

References

Hei Y, Farahbakhshian S, Chen X, Battell M, McNeill J . Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Mol Cell Biochem. 1998; 178(1-2):367-75. DOI: 10.1023/a:1006819906820. View

Rodriguez-Moran M, Guerrero-Romero F . Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003; 26(4):1147-52. DOI: 10.2337/diacare.26.4.1147. View

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J . Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001; 108(8):1167-74. PMC: 209533. DOI: 10.1172/JCI13505. View

Abdullah K, Alam M, Iqbal Z, Naseem I . Therapeutic effect of vitamin B on hyperglycemia, oxidative stress and DNA damage in alloxan induced diabetic rat model. Biomed Pharmacother. 2018; 105:1223-1231. DOI: 10.1016/j.biopha.2018.06.085. View

Kohda Y, Shirakawa H, Yamane K, Otsuka K, Kono T, Terasaki F . Prevention of incipient diabetic cardiomyopathy by high-dose thiamine. J Toxicol Sci. 2008; 33(4):459-72. DOI: 10.2131/jts.33.459. View

Anderson R, Bryden N, Polansky M, Cheng N, Chi J, Feng J . Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997; 46(11):1786-91. DOI: 10.2337/diab.46.11.1786. View

Virag L . Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol. 2005; 3(3):209-14. DOI: 10.2174/1570161054368625. View

Morakinyo A, Samuel T, Adekunbi D . Magnesium upregulates insulin receptor and glucose transporter-4 in streptozotocin-nicotinamide-induced type-2 diabetic rats. Endocr Regul. 2018; 52(1):6-16. DOI: 10.2478/enr-2018-0002. View

Rabbani N, Alam S, Riaz S, Larkin J, Akhtar M, Shafi T . High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia. 2008; 52(2):208-12. DOI: 10.1007/s00125-008-1224-4. View

10.

Reddi A, Bollineni J . Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. Kidney Int. 2001; 59(4):1342-53. DOI: 10.1046/j.1523-1755.2001.0590041342.x. View

11.

Zhao P, Wang J, Ma H, Xiao Y, He L, Tong C . A newly synthetic chromium complex-chromium (D-phenylalanine)3 activates AMP-activated protein kinase and stimulates glucose transport. Biochem Pharmacol. 2008; 77(6):1002-10. DOI: 10.1016/j.bcp.2008.11.018. View

12.

Hua Y, Clark S, Ren J, Sreejayan N . Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem. 2012; 23(4):313-9. PMC: 3308119. DOI: 10.1016/j.jnutbio.2011.11.001. View

13.

Kostov K . Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci. 2019; 20(6). PMC: 6470576. DOI: 10.3390/ijms20061351. View

14.

Guerrero-Romero F, Rodriguez-Moran M . The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens. 2008; 23(4):245-51. DOI: 10.1038/jhh.2008.129. View

15.

Kadkhodaee M, Mikaeili S, Zahmatkesh M, Golab F, Seifi B, Arab H . Alteration of renal functional, oxidative stress and inflammatory indices following hepatic ischemia-reperfusion. Gen Physiol Biophys. 2012; 31(2):195-202. DOI: 10.4149/gpb_2012_024. View

16.

Trujillo J, Chirino Y, Molina-Jijon E, Anderica-Romero A, Tapia E, Pedraza-Chaverri J . Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013; 1:448-56. PMC: 3814973. DOI: 10.1016/j.redox.2013.09.003. View

17.

Bugger H, Abel E . Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014; 57(4):660-71. PMC: 3969857. DOI: 10.1007/s00125-014-3171-6. View

18.

Zaulkffali A, Md Razip N, Alwi S, Abd Jalil A, Mutalib M, Gopalsamy B . Vitamins D and E Stimulate the Signalling Pathway in Insulin-Resistant SK-N-SH Neuronal Cells. Nutrients. 2019; 11(10). PMC: 6836113. DOI: 10.3390/nu11102525. View

19.

Sharaf El Din U, Salem M, Abdulazim D . Diabetic nephropathy: Time to withhold development and progression - A review. J Adv Res. 2017; 8(4):363-373. PMC: 5430158. DOI: 10.1016/j.jare.2017.04.004. View

20.

Barooti A, Kamran M, Kharazmi F, Eftakhar E, Malekzadeh K, Talebi A . Effect of oral magnesium sulfate administration on blood glucose hemostasis via inhibition of gluconeogenesis and FOXO1 gene expression in liver and muscle in diabetic rats. Biomed Pharmacother. 2018; 109:1819-1825. DOI: 10.1016/j.biopha.2018.10.164. View